Every oncologist today faces the same silent pressures:
Infusion chairs full. Charts unfinished. Trial slots empty. Scans waiting for review.
AI isn’t the future — it’s the quiet force turning those bottlenecks into breakthroughs.
Across hospitals and community practices, five early programs are proving that the technology works best not when it replaces judgment, but when it restores it — giving clinicians back time, clarity, and foresight.
🏥 1 | Fixing the Infusion Center Bottleneck
At Vanderbilt University Medical Center, AI took on one of oncology’s most stubborn problems — infusion scheduling chaos.
The Vanderbilt-Ingram Cancer Center implemented LeanTaaS iQueue, a predictive model that rebalanced chair scheduling and nursing assignments. It forecasts workload days ahead and staggers start and disconnect times to prevent “spike hours.”
➡ Impact:
Median wait times dropped 50%. Staffing can now be planned 3–4 days in advance, easing burnout and creating smoother patient flow.
A process once reactive is now orchestrated with precision.
🫁 2 | Catching Cancer Before It Catches Patients
At The Christ Hospital Health Network in Cincinnati, an AI-driven lung nodule detector became a digital second pair of eyes for radiologists — spotting subtle findings buried in routine scans.
➡ Impact:
Within months, 4,200 nodules identified, 100 cancers diagnosed, 50+ treated, and a 93% positive predictive value.
AI amplified human vigilance without slowing workflow.
Each flagged nodule wasn’t just a data point — it was a patient whose outcome changed trajectory.
🧍♀️ 3 | Ending the Documentation Drain
Across The Permanente Medical Group, over 7,000 physicians adopted ambient AI scribes that listen, summarize, and structure clinical notes across 2.5 million+ encounters.
In oncology, where every visit is data-dense and emotionally charged, the effect has been transformational.
➡ Impact:
Over 63 weeks, AI saved 15,791 hours of documentation.
Physicians retained full control — reviewing, editing, and signing off their own notes.
84% reported improved communication; 56% of patients noticed the change.
AI didn’t depersonalize care — it brought the human conversation back into the room.
🔬 4 | Accelerating Precision Medicine and Trial Access
At the Cancer and Blood Specialty Clinic, AI made precision medicine operational.
Through Tempus’ platform and the TIME Trial® Network, clinicians could match patients to therapies and open new studies in weeks, not months.
➡ Impact:
Trial activation times fell from months to 10–14 days.
Across 87 sites, 1.28 million patients were screened for 95+ studies, averaging 1.57 trial consents per day.
This is what it looks like when community oncology moves at the speed of innovation.
🧭 5 | Bringing Trial Matching to the Point of Care
The American Oncology Network (AON) integrated MiBA’s TIPS system directly into its EMR — a small icon that lights up when a patient qualifies for a trial.
➡ Impact:
Opportunities once buried in spreadsheets now surface in real time during the visit.
A simple interface change turned trial access from chance into consistency.
💡 Owning the Future of AI in Oncology
The hardest part of AI isn’t the math — it’s the trust.
Trust that its logic is clear, its data defensible, and its conclusions worthy of a clinician’s signature.
That doesn’t come from regulation alone — it comes from discernment.
For community oncology, this is the moment to lead.
AI shouldn’t be evaluated like software; it should be trained and tested like a new member of the care team — questioned, corrected, and proven.
The practices that will thrive aren’t the ones that adopt the most tools,
but those that govern intelligence as tightly as they govern medicine.
Because AI will not define oncology’s future — oncologists will.
Now, they simply have sharper instruments.
⚙️ What You Can Do Now
Start small. Stay in control. Measure what matters.
- Try an AI scribe for one clinic day. By evening, you’ll know if it earns its keep — or your trust.
- Benchmark your patterns. Use decision support in OncoEMR or Flatiron for quiet insight, no bureaucracy.
- Spot early-risk patients. Platforms like Carevive or Navigating Cancer catch the “Friday at 4 p.m.” declines before they become admissions.
- Hold a ten-minute weekly AI huddle. Review alerts, overrides, and misses — see your data as a mirror, not a metric.
When clinicians lead, AI doesn’t replace judgment — it extends it.
That’s how medicine stays human — and oncology leads with heart and precision into the era of precision oncology.
—————————————
The Compass is your practical briefing on what’s working in oncology care – strategy, science, and systems. No fluff. Just implementation.